CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Basalt Health›
Analysis
Basalt Health

Basalt Health

Basalt Health develops AI-assisted referral review software for post-acute admissions teams.

HQ
New York, NY, US
Founded
2024
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Library

Contents

  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths

Product Overview

Basalt Health offers software for post-acute referral review and admissions workflows. It brings information from a referral packet together with a facility's criteria so staff can assess whether a potential admission warrants further review.

The platform presents supporting source lines for information surfaced during that review, while leaving the admission decision with a clinician. It also organizes clinical evidence for related payer workflows, linking intake review with subsequent documentation without replacing staff judgment.

Market Outlook

Basalt Health addresses the post-acute workflow in which facilities receive referral materials and assess whether they can accept a patient. Its offering targets the information-review and admissions steps between receipt of a packet and the facility's decision.

Facilities evaluating software in this area can consider how a tool handles their own criteria, makes packet evidence available to reviewers, and fits existing admissions work. Basalt's focus speaks to those operational needs, but the cited material does not support a market-size forecast or a claim about future adoption.

Competitive Advantages

Basalt Health emphasizes facility-specific review criteria and source lines tied to incoming referral materials. These features allow a reviewer to trace a surfaced finding back to the packet while applying that facility's own admission requirements.

Other vendors also offer screening of skilled-nursing referrals and admissions tracking, so referral review alone does not distinguish Basalt. The company's described approach combines local criteria, cited packet information, and human decision-making; the available sources do not establish a measured performance advantage over alternatives.